Devgen receives a tender offer from Syngenta of €16 per share for all outstanding shares


Ghent, Belgium – 21 September 2012, 7am CET 
Devgen nv (Euronext Brussels: DEVG), the agro-biotech company that shapes the field of hybrid rice in India and Southeast Asia and innovates in crop protection technologies, today reports that Syngenta has announced an offer to acquire all outstanding shares of Devgen nv at a price of €16 in cash per share. The public tender offer will start after the approval of the bid prospectus and the memorandum of reply by the Belgian Financial Services and Markets Authority (FSMA).

PDF-file 363.3kb